Altered Topological Properties of Functional Brain Network Associated with Alzheimer's Disease

Yongcheng Yao
2023-05-16
Abstract:Functional Magnetic Resonance Imaging (fMRI) is commonly utilized to study human brain activity, including abnormal functional properties related to neurodegenerative diseases. This study aims to investigate the differences in the topological properties of functional brain networks between individuals with Alzheimer's Disease (AD) and normal controls. A total of 590 subjects, consisting of 175 with AD dementia and 415 age-, gender-, and handedness-matched controls, were included. The topological properties of the brain network were quantified using graph-theory-based analyses. The results indicate abnormal network integration and segregation in the AD group. These findings enhance our understanding of AD pathophysiology from a functional brain network structure perspective and may aid in identifying AD biomarkers. Supplementary data to aid in the validation of this research are available at <a class="link-external link-https" href="https://github.com/YongchengYAO/AD-FunctionalBrainNetwork" rel="external noopener nofollow">this https URL</a>.
Neurons and Cognition,Computer Vision and Pattern Recognition
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to study the differences in the topological properties of functional brain networks between Alzheimer's disease (AD) patients and normal control groups. Specifically, the authors used functional magnetic resonance imaging (fMRI) data and quantified the topological characteristics of the brain networks of the two groups of people through graph - theory - based analysis methods, aiming to reveal the abnormal integration and segregation phenomena in the brain networks of AD patients. These findings are helpful to deepen the understanding of the pathophysiological mechanisms of AD from the perspective of the functional brain network structure and may assist in identifying biomarkers of AD. The key points mentioned in the paper include: - **Research Background**: Alzheimer's disease is a common neurodegenerative disease that mainly affects the elderly. Its characteristics include cognitive decline, language impairment, memory problems (especially short - term memory), loss of sense of direction, etc. As the disease progresses, patients may experience severe physical dysfunction and eventually die. AD is the most common form of dementia, accounting for about half of all cases. Early studies have shown that the functional connections in certain brain regions of AD patients are impaired, such as the hippocampus, prefrontal cortex, parietal lobe, precuneus and posterior cingulate gyrus. - **Research Purpose**: By comparing the topological properties of the functional brain networks of AD patients and normal control groups, explore the abnormal changes in the brain networks of AD patients. These changes may be reflected in the integration and segregation characteristics of the brain networks, that is, the degree of connection tightness and modularity between network nodes. - **Research Methods**: - **Data Source**: Use the OASIS - 3 public data set, which contains more than 1,000 participants and more than 2,100 MR scan sessions, covering multiple neuroimaging modalities. - **Image Processing**: Use SPM12 and CONN 18.b toolboxes to pre - process MRI data, including steps such as spatial standardization, segmentation, head - motion estimation and correction, slice - time correction, abnormal scan detection, spatial normalization of BOLD signals and spatial smoothing. - **Graph - theory Analysis**: Construct unweighted bidirectional graphs (brain networks) and quantify the topological properties of the networks through graph - theory indicators, such as degree, clustering coefficient, shortest path length, global efficiency, local efficiency and betweenness centrality. - **Expected Contribution**: Through the above research, the paper hopes to provide new insights into the pathophysiological mechanisms of AD and provide potential biomarkers for the diagnosis and treatment of AD.